Renishaw plc (RSW) PT Raised to GBX 3,630 at Deutsche Bank AG
Renishaw plc (LON:RSW) had its target price boosted by equities research analysts at Deutsche Bank AG from GBX 3,180 ($41.07) to GBX 3,630 ($46.88) in a research report issued to clients and investors on Wednesday. The brokerage currently has a “sell” rating on the stock. Deutsche Bank AG’s target price would indicate a potential downside of 24.11% from the stock’s previous close.
A number of other equities analysts have also recently commented on RSW. Peel Hunt lifted their price objective on shares of Renishaw plc from GBX 3,200 ($41.33) to GBX 4,200 ($54.24) and gave the company a “hold” rating in a report on Tuesday, August 8th. Barclays PLC lifted their price objective on shares of Renishaw plc from GBX 2,620 ($33.84) to GBX 3,880 ($50.11) and gave the company an “underweight” rating in a report on Thursday, August 17th. Finally, Investec reiterated a “hold” rating on shares of Renishaw plc in a report on Friday, August 25th. Two research analysts have rated the stock with a sell rating and five have given a hold rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of GBX 3,572.17 ($46.13).
Renishaw plc (LON RSW) traded down 2.19% during mid-day trading on Wednesday, reaching GBX 4783.00. 157,763 shares of the company’s stock traded hands. The stock has a 50-day moving average price of GBX 4,516.00 and a 200-day moving average price of GBX 3,730.09. Renishaw plc has a 12-month low of GBX 2,355.00 and a 12-month high of GBX 5,030.00. The stock’s market capitalization is GBX 3.48 billion.
Renishaw plc Company Profile
Renishaw plc is a metrology company. The Company operates through two segments: metrology and healthcare. The Company’s metrology products are used in the fields of industrial automation and motion systems. The healthcare products include engineering solutions for stereotactic neurosurgery, diagnosis of infectious diseases, analytical tools that identify and characterize the chemistry and structure of materials, supply of implants to hospitals and specialist design centers for craniomaxillofacial surgery, and products and services that allow dental laboratories to manufacture dental restorations.
Receive News & Ratings for Renishaw plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renishaw plc and related companies with MarketBeat.com's FREE daily email newsletter.